Hyperinflammatory repolarisation of ovarian cancer patient macrophages by anti-tumour IgE antibody, MOv18, restricts an immunosuppressive macrophage:Treg cell interaction
Gabriel Osborn(Guy's Hospital), Sophia N. Karagiannis(King's College London), Chara Stavraka(King's College London), Alicia M. Chenoweth(Guy's Hospital), Shashi Jatiani(Icahn School of Medicine at Mount Sinai), Lais C. G. F. Palhares(Guy's Hospital), Amanda L. Gross(Scientific Systems (United States)), James Spicer(King's College London), Heather J. Bax(King's College London), Rodolfo Bianchini(University of Veterinary Medicine Vienna), Debra H. Josephs(Guy's and St Thomas' NHS Foundation Trust), Theodore Evan(Guy's Hospital), Jitesh Chauhan(King's College London), Leonard Moise(Scientific Systems (United States)), Rebecca Adams(King's College London), Jacobo López‐Abente(Guy's Hospital), Mano Nakamura(King's College London), Sophia Tsoka(King's College London), Roman Laddach(Guy's Hospital), Mariangela Figini(Fondazione IRCCS Istituto Nazionale dei Tumori), Rebecca Kristeleit(Guy's and St Thomas' NHS Foundation Trust), Erika Jensen‐Jarolim(University of Vienna), Ana Montes(Guy's and St Thomas' NHS Foundation Trust), Melanie Grandits(Guy's Hospital), Ahmad Sayasneh(Imperial College Healthcare NHS Trust), Sharmistha Ghosh(Guy's and St Thomas' NHS Foundation Trust), Giulia Pellizzari(King's College London)
Cited by 19
Related Papers
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
|The Lancet Oncology|2021|614
The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution
|Cell|2020|602
Targeting folate receptor alpha for cancer treatment
|Oncotarget|2016|447
Avelumab alone or in combination with chemotherapy versus chemotherapy alone in platinum-resistant or platinum-refractory ovarian cancer (JAVELIN Ovarian 200): an open-label, three-arm, randomised, phase 3 study
|The Lancet Oncology|2021|401
Dysbiosis of the gut and lung microbiome has a role in asthma
|Seminars in Immunopathology|2020|353